GlassScriptPhysician profile
Victor M Martinez
NPI 1124328778
$8,009.05
in general payments reported to CMS, 2019-2025
40 companies · $529 in 2025
The $529 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,259 · 2020: $1,357 · 2021: $1,930 · 2022: $1,075 · 2023: $1,080 · 2024: $779 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,388.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,260.86 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $1,137.71 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $921.30 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amarin Pharma, INC. | $616.04 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $602.43 | 2019-2025 | Synjardy, Jardiance, Tradjenta |
| Abbvie INC. | $345.02 | 2020-2025 | |
| Exact Sciences Corporation | $266.92 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biohaven Pharmaceuticals, INC. | $232.59 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $226.41 | 2019-2022 | |
| Pfizer INC. | $221.97 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $195.14 | 2019-2023 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $186.57 | 2019-2022 | |
| Glaxosmithkline, LLC. | $183.02 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $178.59 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $146.90 | 2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.